IDEAS home Printed from https://ideas.repec.org/a/inm/ormnsc/v69y2023i1p260-282.html
   My bibliography  Save this article

Personalized Disease Screening Decisions Considering a Chronic Condition

Author

Listed:
  • Ali Hajjar

    (Harvard Medical School, Boston, Massachusetts 02115; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts 02114)

  • Oguzhan Alagoz

    (Department of Industrial and Systems Engineering, University of Wisconsin–Madison, Madison, Wisconsin 53705)

Abstract

Clinical practice guidelines do not sufficiently address the needs of patients with chronic conditions as these guidelines focus on single disease management and ignore unique patient-specific conditions. As a result, a nonpersonalized approach to the management of the patients with chronic conditions leads to adverse events and increases the financial burden on the healthcare system as over 150 million Americans experience chronic conditions. To this end, we develop a stochastic modeling framework to personalize the disease screening decisions for patients with or at risk for developing a chronic condition and provide an exact solution algorithm. We consider the optimal management of the screening decisions for an index disease (e.g., breast cancer, colorectal cancer, human immunodeficiency virus, etc.) while accounting for the existence of a chronic condition (e.g., hypertension, diabetes, Alzheimer’s disease, etc.). Our modeling framework is particularly useful for the cases where the chronic condition affects the risk of the index disease. In a case study using real breast cancer epidemiology data, we demonstrate how our modeling framework can be used to personalize breast cancer screening for women with type 2 diabetes. In addition to providing a personalized breast cancer screening schedule for women with diabetes, we find some important policy insights that were not previously recognized by the medical community. More specifically, we find that compared with women without diabetes, women with diabetes should be screened less aggressively, but screening should end at similar ages. We also find that adherence to the optimal screening policy is more crucial for women with diabetes compared with nondiabetic women. Our main insight on screening recommendations also has important resource implications as it leads to fewer screening mammograms. That is, compared with the current national breast cancer screening guidelines, the optimal breast cancer screening policy for women with diabetes could save the healthcare system approximately 2.6 million mammograms annually.

Suggested Citation

  • Ali Hajjar & Oguzhan Alagoz, 2023. "Personalized Disease Screening Decisions Considering a Chronic Condition," Management Science, INFORMS, vol. 69(1), pages 260-282, January.
    • Handle: RePEc:inm:ormnsc:v:69:y:2023:i:1:p:260-282
    DOI: 10.1287/mnsc.2022.4336
    as

    Download full text from publisher

    File URL: http://dx.doi.org/10.1287/mnsc.2022.4336
    Download Restriction: no
    File URL: https://libkey.io/10.1287/mnsc.2022.4336?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Turgay Ayer & Oguzhan Alagoz & Natasha K. Stout, 2012. "OR Forum---A POMDP Approach to Personalize Mammography Screening Decisions," Operations Research, INFORMS, vol. 60(5), pages 1019-1034, October.
    2. Lisa M. Maillart & Julie Simmons Ivy & Scott Ransom & Kathleen Diehl, 2008. "Assessing Dynamic Breast Cancer Screening Policies," Operations Research, INFORMS, vol. 56(6), pages 1411-1427, December.
    3. Fatih Safa Erenay & Oguzhan Alagoz & Adnan Said, 2014. "Optimizing Colonoscopy Screening for Colorectal Cancer Prevention and Surveillance," Manufacturing & Service Operations Management, INFORMS, vol. 16(3), pages 381-400, July.
    4. Richard D. Smallwood & Edward J. Sondik, 1973. "The Optimal Control of Partially Observable Markov Processes over a Finite Horizon," Operations Research, INFORMS, vol. 21(5), pages 1071-1088, October.
    5. Joseph S. Pliskin & Donald S. Shepard & Milton C. Weinstein, 1980. "Utility Functions for Life Years and Health Status," Operations Research, INFORMS, vol. 28(1), pages 206-224, February.
    6. George E. Monahan, 1982. "State of the Art---A Survey of Partially Observable Markov Decision Processes: Theory, Models, and Algorithms," Management Science, INFORMS, vol. 28(1), pages 1-16, January.
    7. Mucahit Cevik & Turgay Ayer & Oguzhan Alagoz & Brian L. Sprague, 2018. "Analysis of Mammography Screening Policies under Resource Constraints," Production and Operations Management, Production and Operations Management Society, vol. 27(5), pages 949-972, May.
    8. Jeanne S. Mandelblatt & Aimee M. Near & Diana L. Miglioretti & Diego Munoz & Brian L. Sprague & Amy Trentham-Dietz & Ronald Gangnon & Allison W. Kurian & Harald Weedon-Fekjaer & Kathleen A. Cronin & S, 2018. "Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling," Medical Decision Making, , vol. 38(1_suppl), pages 9-23, April.
    9. James N. Eagle, 1984. "The Optimal Search for a Moving Target When the Search Path Is Constrained," Operations Research, INFORMS, vol. 32(5), pages 1107-1115, October.
    10. Janel Hanmer & William F. Lawrence & John P. Anderson & Robert M. Kaplan & Dennis G. Fryback, 2006. "Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores," Medical Decision Making, , vol. 26(4), pages 391-400, July.
    11. Elliot Lee & Mariel S. Lavieri & Michael Volk, 2019. "Optimal Screening for Hepatocellular Carcinoma: A Restless Bandit Model," Service Science, INFORMS, vol. 21(1), pages 198-212, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Malek Ebadi & Raha Akhavan-Tabatabaei, 2021. "Personalized Cotesting Policies for Cervical Cancer Screening: A POMDP Approach," Mathematics, MDPI, vol. 9(6), pages 1-20, March.
    2. Robert Kraig Helmeczi & Can Kavaklioglu & Mucahit Cevik & Davood Pirayesh Neghab, 2023. "A multi-objective constrained partially observable Markov decision process model for breast cancer screening," Operational Research, Springer, vol. 23(2), pages 1-42, June.
    3. Turgay Ayer & Oguzhan Alagoz & Natasha K. Stout & Elizabeth S. Burnside, 2016. "Heterogeneity in Women’s Adherence and Its Role in Optimal Breast Cancer Screening Policies," Management Science, INFORMS, vol. 62(5), pages 1339-1362, May.
    4. Mehmet A. Ergun & Ali Hajjar & Oguzhan Alagoz & Murtuza Rampurwala, 2022. "Optimal breast cancer risk reduction policies tailored to personal risk level," Health Care Management Science, Springer, vol. 25(3), pages 363-388, September.
    5. Jue Wang, 2016. "Minimizing the false alarm rate in systems with transient abnormality," Naval Research Logistics (NRL), John Wiley & Sons, vol. 63(4), pages 320-334, June.
    6. Turgay Ayer & Oguzhan Alagoz & Natasha K. Stout, 2012. "OR Forum---A POMDP Approach to Personalize Mammography Screening Decisions," Operations Research, INFORMS, vol. 60(5), pages 1019-1034, October.
    7. Boloori, Alireza & Saghafian, Soroush & Chakkera, Harini A. A. & Cook, Curtiss B., 2017. "Data-Driven Management of Post-transplant Medications: An APOMDP Approach," Working Paper Series rwp17-036, Harvard University, John F. Kennedy School of Government.
    8. Alireza Boloori & Soroush Saghafian & Harini A. Chakkera & Curtiss B. Cook, 2020. "Data-Driven Management of Post-transplant Medications: An Ambiguous Partially Observable Markov Decision Process Approach," Manufacturing & Service Operations Management, INFORMS, vol. 22(5), pages 1066-1087, September.
    9. Jue Wang & Chi-Guhn Lee, 2015. "Multistate Bayesian Control Chart Over a Finite Horizon," Operations Research, INFORMS, vol. 63(4), pages 949-964, August.
    10. Elliot Lee & Mariel Lavieri & Michael Volk & Yongcai Xu, 2015. "Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity," Health Care Management Science, Springer, vol. 18(3), pages 363-375, September.
    11. Zong-Zhi Lin & James C. Bean & Chelsea C. White, 2004. "A Hybrid Genetic/Optimization Algorithm for Finite-Horizon, Partially Observed Markov Decision Processes," INFORMS Journal on Computing, INFORMS, vol. 16(1), pages 27-38, February.
    12. Yanling Chang & Alan Erera & Chelsea White, 2015. "A leader–follower partially observed, multiobjective Markov game," Annals of Operations Research, Springer, vol. 235(1), pages 103-128, December.
    13. Otten, Maarten & Timmer, Judith & Witteveen, Annemieke, 2020. "Stratified breast cancer follow-up using a continuous state partially observable Markov decision process," European Journal of Operational Research, Elsevier, vol. 281(2), pages 464-474.
    14. Li, Weiyu & Denton, Brian T. & Morgan, Todd M., 2023. "Optimizing active surveillance for prostate cancer using partially observable Markov decision processes," European Journal of Operational Research, Elsevier, vol. 305(1), pages 386-399.
    15. Turgay Ayer, 2015. "Inverse optimization for assessing emerging technologies in breast cancer screening," Annals of Operations Research, Springer, vol. 230(1), pages 57-85, July.
    16. Wang, Fan & Zhang, Shengfan & Henderson, Louise M., 2018. "Adaptive decision-making of breast cancer mammography screening: A heuristic-based regression model," Omega, Elsevier, vol. 76(C), pages 70-84.
    17. Zehra Önen Dumlu & Serpil Sayın & İbrahim Hakan Gürvit, 2023. "Screening for preclinical Alzheimer’s disease: Deriving optimal policies using a partially observable Markov model," Health Care Management Science, Springer, vol. 26(1), pages 1-20, March.
    18. Givon, Moshe & Grosfeld-Nir, Abraham, 2008. "Using partially observed Markov processes to select optimal termination time of TV shows," Omega, Elsevier, vol. 36(3), pages 477-485, June.
    19. Zlatana Nenova & Jennifer Shang, 2022. "Personalized Chronic Disease Follow‐Up Appointments: Risk‐Stratified Care Through Big Data," Production and Operations Management, Production and Operations Management Society, vol. 31(2), pages 583-606, February.
    20. Elliot Lee & Mariel S. Lavieri & Michael Volk, 2019. "Optimal Screening for Hepatocellular Carcinoma: A Restless Bandit Model," Service Science, INFORMS, vol. 21(1), pages 198-212, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:inm:ormnsc:v:69:y:2023:i:1:p:260-282. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Asher (email available below). General contact details of provider: https://edirc.repec.org/data/inforea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.